A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Cypermethrin | CAS 52315-07-8 - Request Quote

Picture of Cypermethrin

Cypermethrin

SZ CAT No:SZ-P046004
CAS No
52315-07-8
Mol.F.
C22H19Cl2NO3
Mol.Wt.
416.3
Inv. Status
Synthesis on demand
Shipping Condition Room Temperature

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Cypermethrin is chemically 3-(2,2-Dichloroethenyl)-2,2-dimethylcyclopropanecarboxylic Acid Cyano(3-phenoxyphenyl)methyl Ester. Cypermethrin is supplied with detailed characterization data compliant with regulatory guideline. Cypermethrin can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Permethrin.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 52315-07-8

Purchase 52315-07-8

Order 52315-07-8

Enquire 52315-07-8

price of 52315-07-8

52315-07-8 Supplier

52315-07-8 Manufacturer

52315-07-8 Exporter

buy high quality Cypermethrin

Purchase Cypermethrin

Cypermethrin suppliers

Cypermethrin manufacturers

Cypermethrin price

Order Cypermethrin

Enquire Cypermethrin

Cypermethrin cost

Cypermethrin Supplier

Cypermethrin Distributor

Cypermethrin for Method Validation

Permethrin Reference Standard

Cypermethrin for ANDA Filing

Cypermethrin for Forced Degradation Studies

Cypermethrin Identification Standards

Cypermethrin for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,